Investors | News | Contact Us | Join E-mail List | Careers   

Home | LuViva | Technology | Clinical Trials

 

News and Events

Guided Therapeutics Reports Second Quarter 2011 Results

Guided Therapeutics Begins Human Feasibility Clinical Study for Light-based Barrett’s Esophagus Technology Jointly Developed with Konica Minolta Opto

Guided Therapeutics to Report Q2 2011 Results and Hold Conference Call

Guided Therapeutics Enters into Preliminary Research Agreement with Konica Minolta Opto in Anticipation of Asian Distribution; Plan to Initiate Screening Trials for LuViva Advanced Cervical Scan

Guided Therapeutics Provides Progress Update on its Response to FDA Questions

Guided Therapeutics Reports First Quarter 2011 Results

Study Indicates Guided Therapeutics’ LuViva Advanced Cervical Scan Has Potential to Detect Disease Early and Reduce Unnecessary Biopsies for Women

Guided Therapeutics Introduces LuViva™; New Branding for Cervical Disease Detection Technology

Guided Therapeutics Holds Productive Meeting with FDA on PMA Review of Cervical Cancer Test

Guided Therapeutics Reports Fourth Quarter and Year End 2010 Results

Konica Minolta Opto, Inc. Extends Product Development Licensing Agreement with $750,000 Payment to Guided Therapeutics

Guided Therapeutics Granted Approval for Human Clinical Studies of Light-based Test for Barrett’s Esophagus Pipeline Product

Guided Therapeutics Provides Update on FDA PMA Review of Cervical Cancer Test

Guided Therapeutics’ Cervical Disease Detection Technology to be the Subject of a Presentation at the Upcoming ACOG Annual Meeting

Guided Therapeutics’ Cervical Disease Technology Accepted for Presentation at Major European Scientific Conference

Guided Therapeutics Receives ISO Certification

Guided Therapeutics ISO Certificate

Guided Therapeutics' Presentation at the Sidoti & Company Conference

FDA Accepts Guided Therapeutics’ Non-Invasive Cervical Cancer Scanner PMA Application for Review

Guided Therapeutics Reports Third Quarter 2010 Results

Guided Therapeutics Awarded Federal Grant

Guided Therapeutics Files Premarket Approval Application for Non-Invasive Cervical Cancer Scanner with FDA

Guided Therapeutics Completes $3 Million Financing

National Cancer Institute Funds Second Year of Grant to Guided Therapeutics to Commercialize Non-invasive Cervical Cancer Detection Device

Guided Therapeutics Reports Second Quarter 2010 Results

Guided Therapeutics’ Stock Moves Up From Pink Sheets to OTC Bulletin Board

Leading Expert in Women’s Health Elected to Guided Therapeutics Board of Directors

Guided Therapeutics Reports First Quarter 2010 Results

GT’s Cervical Scan Could Save Money, Reduce Suffering According to Results Presented at Europe’s Foremost International Congress for OB-GYN

 

 

New Science and Technology devoted to painlessly detecting cervical disease before it becomes cancer and helping to preserve reproductive health.

Presentation to ACOG May 2011

 

Partner Information

  

©2011 Guided Therapeutics, Inc.

5835 Peachtree Corners East

Suite D

Norcross, GA 30092

770-242-8723

770-242-8639 - Fax

www.guidedinc.com

info@guidedinc.com

Terms of Service
cervical cancer, cervical cancer vaccine, spectrx, HPV, Pap test, pap smear, Human Papilloma virus, Human Papillomavirus, noninvasive, non-invasive, cancer detection, cancer products